APO Research

APO RESEARCH · REPORT

Metabotropic Glutamate Receptor (MRG)

Selected research

Industry Growth & Trends

Global Metabotropic Glutamate Receptor (MRG) Industry Growth and Trends Forecast to 2032

Market perspective

The global Metabotropic Glutamate Receptor (MRG) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Metabotropic Glutamate Receptor (MRG) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Metabotropic Glutamate Receptor (MRG) is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Metabotropic Glutamate Receptor (MRG) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Metabotropic Glutamate Receptor (MRG) include Taisho Pharmaceutical Holding, Prexton Therapeutics, Medgenics, Domain Therapeutics and Addex Therapeutics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Metabotropic Glutamate Receptor (MRG) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Metabotropic Glutamate Receptor (MRG) market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Metabotropic Glutamate Receptor (MRG) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Metabotropic Glutamate Receptor (MRG).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Metabotropic Glutamate Receptor (MRG) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Metabotropic Glutamate Receptor (MRG) Market by Company

Taisho Pharmaceutical Holding

Prexton Therapeutics

Medgenics

Domain Therapeutics

Addex Therapeutics

Metabotropic Glutamate Receptor (MRG) Segment by Type

mGluR5

mGluR4

mGluR2

Metabotropic Glutamate Receptor (MRG) Segment by Application

Meningitis

Septicemia

Others

Metabotropic Glutamate Receptor (MRG) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Metabotropic Glutamate Receptor (MRG) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Metabotropic Glutamate Receptor (MRG) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Metabotropic Glutamate Receptor (MRG).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Metabotropic Glutamate Receptor (MRG) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Metabotropic Glutamate Receptor (MRG) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of mGluR5 Table 2. Major Company of mGluR4 Table 3. Major Company of mGluR2 Table 4. Global Metabotropic Glutamate Receptor (MRG) Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Metabotropic Glutamate Receptor (MRG) Sales by Type (2021-2026) & (k units) Table 6. Global Metabotropic Glutamate Receptor (MRG) Sales Market Share in Volume by Type (2021-2026) Table 7. Global Metabotropic Glutamate Receptor (MRG) Sales by Type (2021-2026) & (US$ Million) Table 8. Global Metabotropic Glutamate Receptor (MRG) Sales Market Share in Value by Type (2021-2026) Table 9. Global Metabotropic Glutamate Receptor (MRG) Price by Type (2021-2026) & (US$/unit) Table 10. Global Metabotropic Glutamate Receptor (MRG) Sales by Type (2027-2032) & (k units) Table 11. Global Metabotropic Glutamate Receptor (MRG) Sales Market Share in Volume by Type (2027-2032) Table 12. Global Metabotropic Glutamate Receptor (MRG) Sales by Type (2027-2032) & (US$ Million) Table 13. Global Metabotropic Glutamate Receptor (MRG) Sales Market Share in Value by Type (2027-2032) Table 14. Global Metabotropic Glutamate Receptor (MRG) Price by Type (2027-2032) & (US$/unit) Table 15. North America Metabotropic Glutamate Receptor (MRG) Sales by Type (2021-2026) & (k units) Table 16. North America Metabotropic Glutamate Receptor (MRG) Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Metabotropic Glutamate Receptor (MRG) Sales by Type (2021-2026) & (k units) Table 18. Europe Metabotropic Glutamate Receptor (MRG) Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Metabotropic Glutamate Receptor (MRG) Sales by Type (2021-2026) & (k units) Table 20. Asia-Pacific Metabotropic Glutamate Receptor (MRG) Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Metabotropic Glutamate Receptor (MRG) Sales by Type (2021-2026) & (k units) Table 22. Latin America Metabotropic Glutamate Receptor (MRG) Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Metabotropic Glutamate Receptor (MRG) Sales by Type (2021-2026) & (k units) Table 24. Middle East and Africa Metabotropic Glutamate Receptor (MRG) Sales by Type (2021-2026) & (US$ Million) Table 25. Metabotropic Glutamate Receptor (MRG) Industry Trends Table 26. Metabotropic Glutamate Receptor (MRG) Industry Drivers Table 27. Metabotropic Glutamate Receptor (MRG) Industry Opportunities and Challenges Table 28. Metabotropic Glutamate Receptor (MRG) Industry Restraints Table 29. Global Metabotropic Glutamate Receptor (MRG) Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Metabotropic Glutamate Receptor (MRG) Revenue Market Share by Company (2021-2026) Table 31. Global Metabotropic Glutamate Receptor (MRG) Sales by Company (2021-2026) & (k units) Table 32. Global Metabotropic Glutamate Receptor (MRG) Sales Share by Company (2021-2026) Table 33. Global Metabotropic Glutamate Receptor (MRG) Market Price by Company (2021-2026) & (US$/unit) Table 34. Global Metabotropic Glutamate Receptor (MRG) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Metabotropic Glutamate Receptor (MRG) Major Company Production Sites and Headquarters Table 36. Global Metabotropic Glutamate Receptor (MRG) Company, Product Type & Application Table 37. Global Metabotropic Glutamate Receptor (MRG) Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Metabotropic Glutamate Receptor (MRG) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Metabotropic Glutamate Receptor (MRG) Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Metabotropic Glutamate Receptor (MRG) Sales by Region (2021-2026) & (k units) Table 42. Global Metabotropic Glutamate Receptor (MRG) Sales Market Share in Volume by Region (2021-2026) Table 43. Global Metabotropic Glutamate Receptor (MRG) Sales by Region (2021-2026) & (US$ Million) Table 44. Global Metabotropic Glutamate Receptor (MRG) Sales Market Share in Value by Region (2021-2026) Table 45. Global Metabotropic Glutamate Receptor (MRG) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Global Metabotropic Glutamate Receptor (MRG) Sales by Region (2027-2032) & (k units) Table 47. Global Metabotropic Glutamate Receptor (MRG) Sales Market Share in Volume by Region (2027-2032) Table 48. Global Metabotropic Glutamate Receptor (MRG) Sales by Region (2027-2032) & (US$ Million) Table 49. Global Metabotropic Glutamate Receptor (MRG) Sales Market Share in Value by Region (2027-2032) Table 50. Global Metabotropic Glutamate Receptor (MRG) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 51. Global Metabotropic Glutamate Receptor (MRG) Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Metabotropic Glutamate Receptor (MRG) Sales by Application (2021-2026) & (k units) Table 53. Global Metabotropic Glutamate Receptor (MRG) Sales Market Share in Volume by Application (2021-2026) Table 54. Global Metabotropic Glutamate Receptor (MRG) Sales by Application (2021-2026) & (US$ Million) Table 55. Global Metabotropic Glutamate Receptor (MRG) Sales Market Share in Value by Application (2021-2026) Table 56. Global Metabotropic Glutamate Receptor (MRG) Price by Application (2021-2026) & (US$/unit) Table 57. Global Metabotropic Glutamate Receptor (MRG) Sales by Application (2027-2032) & (k units) Table 58. Global Metabotropic Glutamate Receptor (MRG) Sales Market Share in Volume by Application (2027-2032) Table 59. Global Metabotropic Glutamate Receptor (MRG) Sales by Application (2027-2032) & (US$ Million) Table 60. Global Metabotropic Glutamate Receptor (MRG) Sales Market Share in Value by Application (2027-2032) Table 61. Global Metabotropic Glutamate Receptor (MRG) Price by Application (2027-2032) & (US$/unit) Table 62. North America Metabotropic Glutamate Receptor (MRG) Sales by Application (2021-2026) & (k units) Table 63. North America Metabotropic Glutamate Receptor (MRG) Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Metabotropic Glutamate Receptor (MRG) Sales by Application (2021-2026) & (k units) Table 65. Europe Metabotropic Glutamate Receptor (MRG) Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Metabotropic Glutamate Receptor (MRG) Sales by Application (2021-2026) & (k units) Table 67. Asia-Pacific Metabotropic Glutamate Receptor (MRG) Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Metabotropic Glutamate Receptor (MRG) Sales by Application (2021-2026) & (k units) Table 69. Latin America Metabotropic Glutamate Receptor (MRG) Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Metabotropic Glutamate Receptor (MRG) Sales by Application (2021-2026) & (k units) Table 71. Middle East and Africa Metabotropic Glutamate Receptor (MRG) Sales by Application (2021-2026) & (US$ Million) Table 72. Taisho Pharmaceutical Holding Company Information Table 73. Taisho Pharmaceutical Holding Business Overview Table 74. Taisho Pharmaceutical Holding Metabotropic Glutamate Receptor (MRG) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Taisho Pharmaceutical Holding Metabotropic Glutamate Receptor (MRG) Product Portfolio Table 76. Taisho Pharmaceutical Holding Recent Development Table 77. Prexton Therapeutics Company Information Table 78. Prexton Therapeutics Business Overview Table 79. Prexton Therapeutics Metabotropic Glutamate Receptor (MRG) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Prexton Therapeutics Metabotropic Glutamate Receptor (MRG) Product Portfolio Table 81. Prexton Therapeutics Recent Development Table 82. Medgenics Company Information Table 83. Medgenics Business Overview Table 84. Medgenics Metabotropic Glutamate Receptor (MRG) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Medgenics Metabotropic Glutamate Receptor (MRG) Product Portfolio Table 86. Medgenics Recent Development Table 87. Domain Therapeutics Company Information Table 88. Domain Therapeutics Business Overview Table 89. Domain Therapeutics Metabotropic Glutamate Receptor (MRG) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Domain Therapeutics Metabotropic Glutamate Receptor (MRG) Product Portfolio Table 91. Domain Therapeutics Recent Development Table 92. Addex Therapeutics Company Information Table 93. Addex Therapeutics Business Overview Table 94. Addex Therapeutics Metabotropic Glutamate Receptor (MRG) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Addex Therapeutics Metabotropic Glutamate Receptor (MRG) Product Portfolio Table 96. Addex Therapeutics Recent Development Table 97. North America Metabotropic Glutamate Receptor (MRG) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 98. North America Metabotropic Glutamate Receptor (MRG) Sales by Country (2021-2026) & (k units) Table 99. North America Metabotropic Glutamate Receptor (MRG) Sales Market Share by Country (2021-2026) Table 100. North America Metabotropic Glutamate Receptor (MRG) Sales Forecast by Country (2027-2032) & (k units) Table 101. North America Metabotropic Glutamate Receptor (MRG) Sales Market Share Forecast by Country (2027-2032) Table 102. North America Metabotropic Glutamate Receptor (MRG) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 103. North America Metabotropic Glutamate Receptor (MRG) Market Size by Country (2021-2026) & (US$ Million) Table 104. North America Metabotropic Glutamate Receptor (MRG) Market Share by Country (2021-2026) Table 105. North America Metabotropic Glutamate Receptor (MRG) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 106. North America Metabotropic Glutamate Receptor (MRG) Market Share Forecast by Country (2027-2032) Table 107. Europe Metabotropic Glutamate Receptor (MRG) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 108. Europe Metabotropic Glutamate Receptor (MRG) Sales by Country (2021-2026) & (k units) Table 109. Europe Metabotropic Glutamate Receptor (MRG) Sales Market Share by Country (2021-2026) Table 110. Europe Metabotropic Glutamate Receptor (MRG) Sales Forecast by Country (2027-2032) & (k units) Table 111. Europe Metabotropic Glutamate Receptor (MRG) Sales Market Share Forecast by Country (2027-2032) Table 112. Europe Metabotropic Glutamate Receptor (MRG) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 113. Europe Metabotropic Glutamate Receptor (MRG) Market Size by Country (2021-2026) & (US$ Million) Table 114. Europe Metabotropic Glutamate Receptor (MRG) Market Share by Country (2021-2026) Table 115. Europe Metabotropic Glutamate Receptor (MRG) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 116. Europe Metabotropic Glutamate Receptor (MRG) Market Share Forecast by Country (2027-2032) Table 117. Asia-Pacific Metabotropic Glutamate Receptor (MRG) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 118. Asia-Pacific Metabotropic Glutamate Receptor (MRG) Sales by Country (2021-2026) & (k units) Table 119. Asia-Pacific Metabotropic Glutamate Receptor (MRG) Sales Market Share by Country (2021-2026) Table 120. Asia-Pacific Metabotropic Glutamate Receptor (MRG) Sales Forecast by Country (2027-2032) & (k units) Table 121. Asia-Pacific Metabotropic Glutamate Receptor (MRG) Sales Market Share Forecast by Country (2027-2032) Table 122. Asia-Pacific Metabotropic Glutamate Receptor (MRG) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 123. Asia-Pacific Metabotropic Glutamate Receptor (MRG) Market Size by Country (2021-2026) & (US$ Million) Table 124. Asia-Pacific Metabotropic Glutamate Receptor (MRG) Market Share by Country (2021-2026) Table 125. Asia-Pacific Metabotropic Glutamate Receptor (MRG) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 126. Asia-Pacific Metabotropic Glutamate Receptor (MRG) Market Share Forecast by Country (2027-2032) Table 127. Latin America Metabotropic Glutamate Receptor (MRG) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 128. Latin America Metabotropic Glutamate Receptor (MRG) Sales by Country (2021-2026) & (k units) Table 129. Latin America Metabotropic Glutamate Receptor (MRG) Sales Market Share by Country (2021-2026) Table 130. Latin America Metabotropic Glutamate Receptor (MRG) Sales Forecast by Country (2027-2032) & (k units) Table 131. Latin America Metabotropic Glutamate Receptor (MRG) Sales Market Share Forecast by Country (2027-2032) Table 132. Latin America Metabotropic Glutamate Receptor (MRG) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. Latin America Metabotropic Glutamate Receptor (MRG) Market Size by Country (2021-2026) & (US$ Million) Table 134. Latin America Metabotropic Glutamate Receptor (MRG) Market Share by Country (2021-2026) Table 135. Latin America Metabotropic Glutamate Receptor (MRG) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. Latin America Metabotropic Glutamate Receptor (MRG) Market Share Forecast by Country (2027-2032) Table 137. Middle East and Africa Metabotropic Glutamate Receptor (MRG) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 138. Middle East and Africa Metabotropic Glutamate Receptor (MRG) Sales by Country (2021-2026) & (k units) Table 139. Middle East and Africa Metabotropic Glutamate Receptor (MRG) Sales Market Share by Country (2021-2026) Table 140. Middle East and Africa Metabotropic Glutamate Receptor (MRG) Sales Forecast by Country (2027-2032) & (k units) Table 141. Middle East and Africa Metabotropic Glutamate Receptor (MRG) Sales Market Share Forecast by Country (2027-2032) Table 142. Middle East and Africa Metabotropic Glutamate Receptor (MRG) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Middle East and Africa Metabotropic Glutamate Receptor (MRG) Market Size by Country (2021-2026) & (US$ Million) Table 144. Middle East and Africa Metabotropic Glutamate Receptor (MRG) Market Share by Country (2021-2026) Table 145. Middle East and Africa Metabotropic Glutamate Receptor (MRG) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Middle East and Africa Metabotropic Glutamate Receptor (MRG) Market Share Forecast by Country (2027-2032) Table 147. Key Raw Materials Table 148. Raw Materials Key Suppliers Table 149. Metabotropic Glutamate Receptor (MRG) Distributors List Table 150. Metabotropic Glutamate Receptor (MRG) Customers List Table 151. Research Programs/Design for This Report Table 152. Authors List of This Report Table 153. Secondary Sources Table 154. Primary Sources List of Figures Figure 1. Metabotropic Glutamate Receptor (MRG) Image Figure 2. Global Metabotropic Glutamate Receptor (MRG) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Metabotropic Glutamate Receptor (MRG) Market Size (2021-2032) & (US$ Million) Figure 4. Global Metabotropic Glutamate Receptor (MRG) Sales (2021-2032) & (k units) Figure 5. mGluR5 Image Figure 6. Global mGluR5 Sales YoY Growth (2021-2032) & (k units) Figure 7. mGluR4 Image Figure 8. Global mGluR4 Sales YoY Growth (2021-2032) & (k units) Figure 9. mGluR2 Image Figure 10. Global mGluR2 Sales YoY Growth (2021-2032) & (k units) Figure 11. Global Metabotropic Glutamate Receptor (MRG) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Metabotropic Glutamate Receptor (MRG) Market Share by Type 2025 VS 2032 Figure 13. North America Metabotropic Glutamate Receptor (MRG) Sales Market Share in Volume by Type in 2025 Figure 14. North America Metabotropic Glutamate Receptor (MRG) Sales Market Share in Value by Type in 2025 Figure 15. Europe Metabotropic Glutamate Receptor (MRG) Sales Market Share in Volume by Type in 2025 Figure 16. Europe Metabotropic Glutamate Receptor (MRG) Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Metabotropic Glutamate Receptor (MRG) Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Metabotropic Glutamate Receptor (MRG) Sales Market Share in Value by Type in 2025 Figure 19. Latin America Metabotropic Glutamate Receptor (MRG) Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Metabotropic Glutamate Receptor (MRG) Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Metabotropic Glutamate Receptor (MRG) Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Metabotropic Glutamate Receptor (MRG) Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Metabotropic Glutamate Receptor (MRG) Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Meningitis Image Figure 26. Global Meningitis Sales YoY Growth (2021-2032) & (k units) Figure 27. Septicemia Image Figure 28. Global Septicemia Sales YoY Growth (2021-2032) & (k units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 31. Global Metabotropic Glutamate Receptor (MRG) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Metabotropic Glutamate Receptor (MRG) Market Share by Application 2025 VS 2032 Figure 33. North America Metabotropic Glutamate Receptor (MRG) Sales Market Share in Volume by Application in 2025 Figure 34. North America Metabotropic Glutamate Receptor (MRG) Sales Market Share in Value by Application in 2025 Figure 35. Europe Metabotropic Glutamate Receptor (MRG) Sales Market Share in Volume by Application in 2025 Figure 36. Europe Metabotropic Glutamate Receptor (MRG) Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Metabotropic Glutamate Receptor (MRG) Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Metabotropic Glutamate Receptor (MRG) Sales Market Share in Value by Application in 2025 Figure 39. Latin America Metabotropic Glutamate Receptor (MRG) Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Metabotropic Glutamate Receptor (MRG) Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Metabotropic Glutamate Receptor (MRG) Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Metabotropic Glutamate Receptor (MRG) Sales Market Share in Value by Application in 2025 Figure 43. North America Metabotropic Glutamate Receptor (MRG) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. North America Metabotropic Glutamate Receptor (MRG) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Metabotropic Glutamate Receptor (MRG) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Metabotropic Glutamate Receptor (MRG) Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Metabotropic Glutamate Receptor (MRG) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Europe Metabotropic Glutamate Receptor (MRG) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Metabotropic Glutamate Receptor (MRG) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Metabotropic Glutamate Receptor (MRG) Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Metabotropic Glutamate Receptor (MRG) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Asia-Pacific Metabotropic Glutamate Receptor (MRG) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Metabotropic Glutamate Receptor (MRG) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Metabotropic Glutamate Receptor (MRG) Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Metabotropic Glutamate Receptor (MRG) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Latin America Metabotropic Glutamate Receptor (MRG) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Metabotropic Glutamate Receptor (MRG) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Metabotropic Glutamate Receptor (MRG) Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Metabotropic Glutamate Receptor (MRG) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Middle East and Africa Metabotropic Glutamate Receptor (MRG) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Metabotropic Glutamate Receptor (MRG) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Metabotropic Glutamate Receptor (MRG) Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Metabotropic Glutamate Receptor (MRG) Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Metabotropic Glutamate Receptor (MRG) Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • mGluR5
  • mGluR4
  • mGluR2
Applications
  • Meningitis
  • Septicemia
  • Others
Companies covered
  • Taisho Pharmaceutical Holding
  • Prexton Therapeutics
  • Medgenics
  • Domain Therapeutics
  • Addex Therapeutics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Metabotropic Glutamate Receptor (MRG) Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Metabotropic Glutamate Receptor (MRG) Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Metabotropic Glutamate Receptor (MRG) Market by Type
  6. 1.3.1 mGluR5
  7. 1.3.2 mGluR4
  8. 1.3.3 mGluR2
  9. 1.4 Global Metabotropic Glutamate Receptor (MRG) Market Size by Type
  10. 1.4.1 Global Metabotropic Glutamate Receptor (MRG) Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Metabotropic Glutamate Receptor (MRG) Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Metabotropic Glutamate Receptor (MRG) Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Metabotropic Glutamate Receptor (MRG) Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Metabotropic Glutamate Receptor (MRG) Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Metabotropic Glutamate Receptor (MRG) Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Metabotropic Glutamate Receptor (MRG) Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Metabotropic Glutamate Receptor (MRG) Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Metabotropic Glutamate Receptor (MRG) Industry Trends
  2. 2.2 Metabotropic Glutamate Receptor (MRG) Industry Drivers
  3. 2.3 Metabotropic Glutamate Receptor (MRG) Industry Opportunities and Challenges
  4. 2.4 Metabotropic Glutamate Receptor (MRG) Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Metabotropic Glutamate Receptor (MRG) Revenue (2021-2026)
  2. 3.2 Global Top Players by Metabotropic Glutamate Receptor (MRG) Sales (2021-2026)
  3. 3.3 Global Top Players by Metabotropic Glutamate Receptor (MRG) Price (2021-2026)
  4. 3.4 Global Metabotropic Glutamate Receptor (MRG) Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Metabotropic Glutamate Receptor (MRG) Major Company Production Sites & Headquarters
  6. 3.6 Global Metabotropic Glutamate Receptor (MRG) Company, Product Type & Application
  7. 3.7 Global Metabotropic Glutamate Receptor (MRG) Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Metabotropic Glutamate Receptor (MRG) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Metabotropic Glutamate Receptor (MRG) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Metabotropic Glutamate Receptor (MRG) Tier 1, Tier 2, and Tier 3
4 Metabotropic Glutamate Receptor (MRG) Regional Status and Outlook
  1. 4.1 Global Metabotropic Glutamate Receptor (MRG) Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Metabotropic Glutamate Receptor (MRG) Historic Market Size by Region
  3. 4.2.1 Global Metabotropic Glutamate Receptor (MRG) Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Metabotropic Glutamate Receptor (MRG) Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Metabotropic Glutamate Receptor (MRG) Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Metabotropic Glutamate Receptor (MRG) Forecasted Market Size by Region
  7. 4.3.1 Global Metabotropic Glutamate Receptor (MRG) Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Metabotropic Glutamate Receptor (MRG) Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Metabotropic Glutamate Receptor (MRG) Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Metabotropic Glutamate Receptor (MRG) by Application
  1. 5.1 Metabotropic Glutamate Receptor (MRG) Market by Application
  2. 5.1.1 Meningitis
  3. 5.1.2 Septicemia
  4. 5.1.3 Others
  5. 5.2 Global Metabotropic Glutamate Receptor (MRG) Market Size by Application
  6. 5.2.1 Global Metabotropic Glutamate Receptor (MRG) Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Metabotropic Glutamate Receptor (MRG) Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Metabotropic Glutamate Receptor (MRG) Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Metabotropic Glutamate Receptor (MRG) Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Metabotropic Glutamate Receptor (MRG) Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Metabotropic Glutamate Receptor (MRG) Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Metabotropic Glutamate Receptor (MRG) Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Metabotropic Glutamate Receptor (MRG) Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Taisho Pharmaceutical Holding
  2. 6.1.1 Taisho Pharmaceutical Holding Company Information
  3. 6.1.2 Taisho Pharmaceutical Holding Business Overview
  4. 6.1.3 Taisho Pharmaceutical Holding Metabotropic Glutamate Receptor (MRG) Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Taisho Pharmaceutical Holding Metabotropic Glutamate Receptor (MRG) Product Portfolio
  6. 6.1.5 Taisho Pharmaceutical Holding Recent Developments
  7. 6.2 Prexton Therapeutics
  8. 6.2.1 Prexton Therapeutics Company Information
  9. 6.2.2 Prexton Therapeutics Business Overview
  10. 6.2.3 Prexton Therapeutics Metabotropic Glutamate Receptor (MRG) Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Prexton Therapeutics Metabotropic Glutamate Receptor (MRG) Product Portfolio
  12. 6.2.5 Prexton Therapeutics Recent Developments
  13. 6.3 Medgenics
  14. 6.3.1 Medgenics Company Information
  15. 6.3.2 Medgenics Business Overview
  16. 6.3.3 Medgenics Metabotropic Glutamate Receptor (MRG) Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Medgenics Metabotropic Glutamate Receptor (MRG) Product Portfolio
  18. 6.3.5 Medgenics Recent Developments
  19. 6.4 Domain Therapeutics
  20. 6.4.1 Domain Therapeutics Company Information
  21. 6.4.2 Domain Therapeutics Business Overview
  22. 6.4.3 Domain Therapeutics Metabotropic Glutamate Receptor (MRG) Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Domain Therapeutics Metabotropic Glutamate Receptor (MRG) Product Portfolio
  24. 6.4.5 Domain Therapeutics Recent Developments
  25. 6.5 Addex Therapeutics
  26. 6.5.1 Addex Therapeutics Company Information
  27. 6.5.2 Addex Therapeutics Business Overview
  28. 6.5.3 Addex Therapeutics Metabotropic Glutamate Receptor (MRG) Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Addex Therapeutics Metabotropic Glutamate Receptor (MRG) Product Portfolio
  30. 6.5.5 Addex Therapeutics Recent Developments
7 North America by Country
  1. 7.1 North America Metabotropic Glutamate Receptor (MRG) Sales by Country
  2. 7.1.1 North America Metabotropic Glutamate Receptor (MRG) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Metabotropic Glutamate Receptor (MRG) Sales by Country (2021-2026)
  4. 7.1.3 North America Metabotropic Glutamate Receptor (MRG) Sales Forecast by Country (2027-2032)
  5. 7.2 North America Metabotropic Glutamate Receptor (MRG) Market Size by Country
  6. 7.2.1 North America Metabotropic Glutamate Receptor (MRG) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Metabotropic Glutamate Receptor (MRG) Market Size by Country (2021-2026)
  8. 7.2.3 North America Metabotropic Glutamate Receptor (MRG) Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Metabotropic Glutamate Receptor (MRG) Sales by Country
  2. 8.1.1 Europe Metabotropic Glutamate Receptor (MRG) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Metabotropic Glutamate Receptor (MRG) Sales by Country (2021-2026)
  4. 8.1.3 Europe Metabotropic Glutamate Receptor (MRG) Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Metabotropic Glutamate Receptor (MRG) Market Size by Country
  6. 8.2.1 Europe Metabotropic Glutamate Receptor (MRG) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Metabotropic Glutamate Receptor (MRG) Market Size by Country (2021-2026)
  8. 8.2.3 Europe Metabotropic Glutamate Receptor (MRG) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Metabotropic Glutamate Receptor (MRG) Sales by Country
  2. 9.1.1 Asia-Pacific Metabotropic Glutamate Receptor (MRG) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Metabotropic Glutamate Receptor (MRG) Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Metabotropic Glutamate Receptor (MRG) Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Metabotropic Glutamate Receptor (MRG) Market Size by Country
  6. 9.2.1 Asia-Pacific Metabotropic Glutamate Receptor (MRG) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Metabotropic Glutamate Receptor (MRG) Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Metabotropic Glutamate Receptor (MRG) Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Metabotropic Glutamate Receptor (MRG) Sales by Country
  2. 10.1.1 South America Metabotropic Glutamate Receptor (MRG) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Metabotropic Glutamate Receptor (MRG) Sales by Country (2021-2026)
  4. 10.1.3 South America Metabotropic Glutamate Receptor (MRG) Sales Forecast by Country (2027-2032)
  5. 10.2 South America Metabotropic Glutamate Receptor (MRG) Market Size by Country
  6. 10.2.1 South America Metabotropic Glutamate Receptor (MRG) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Metabotropic Glutamate Receptor (MRG) Market Size by Country (2021-2026)
  8. 10.2.3 South America Metabotropic Glutamate Receptor (MRG) Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Metabotropic Glutamate Receptor (MRG) Sales by Country
  2. 11.1.1 Middle East and Africa Metabotropic Glutamate Receptor (MRG) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Metabotropic Glutamate Receptor (MRG) Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Metabotropic Glutamate Receptor (MRG) Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Metabotropic Glutamate Receptor (MRG) Market Size by Country
  6. 11.2.1 Middle East and Africa Metabotropic Glutamate Receptor (MRG) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Metabotropic Glutamate Receptor (MRG) Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Metabotropic Glutamate Receptor (MRG) Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Metabotropic Glutamate Receptor (MRG) Value Chain Analysis
  2. 12.1.1 Metabotropic Glutamate Receptor (MRG) Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Metabotropic Glutamate Receptor (MRG) Production Mode & Process
  7. 12.2 Metabotropic Glutamate Receptor (MRG) Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Metabotropic Glutamate Receptor (MRG) Distributors
  10. 12.2.3 Metabotropic Glutamate Receptor (MRG) Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research